Michał Dębczyński

Immunotherapy in patients with non-small cell lung cancer with ECOG PS 2

R. Mroz, Damian Mojsak, Beata Kuklińska, 2021, Contemporary oncology.

The Many Faces of Immune Checkpoint Inhibitor-Associated Pneumonitis: 4 Case Reports

R. Mroz, A. Moniuszko-Malinowska, Damian Mojsak, 2022, The American journal of case reports.

Ewing's Sarcoma in a 58-Year-Old Man: Oncological Diagnosis in the Time of COVID-19

R. Mroz, Damian Mojsak, Beata Kuklińska, 2022, Clinical Cancer Investigation Journal.

A 75-Year-Old Female Smoker with Advanced Small-Cell Lung Cancer and Eastern Cooperative Oncology Group Performance Status 2 who Responded to Combination Immunochemotherapy with Atezolizumab, Etoposide, and Carboplatin

R. Mroz, Damian Mojsak, Beata Kuklińska, 2022, The American journal of case reports.

Self-management and integrated pulmonary care as an essential part of treatment of patients with chronic obstructive pulmonary disease.

R. Mroz, Katarzyna Guziejko, Michał Dębczyński, 2021, Advances in respiratory medicine.

Genome-engineering technologies for modeling and treatment of cystic fibrosis.

Ł. Minarowski, R. Mroz, P. Lisowski, 2023, Advances in medical sciences.

Impact of COVID-19 in Patients with Lung Cancer: A Descriptive Analysis

Ł. Minarowski, P. Czupryna, R. Mroz, 2023, International journal of environmental research and public health.

ATP12A Proton Pump as an Emerging Therapeutic Target in Cystic Fibrosis and Other Respiratory Diseases

G. Gorrieri, P. Scudieri, Damian Mojsak, 2023, Biomolecules.